|
Volumn 184, Issue 3, 2001, Pages 373-376
|
Effects of anti-inflammatory agents on serum levels of calcitonin precursors during human experimental endotoxemia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACUTE PHASE PROTEIN;
ANTIINFLAMMATORY AGENT;
C REACTIVE PROTEIN;
CALCITONIN;
CYTOKINE;
ENDOTOXIN;
ETANERCEPT;
IBUPROFEN;
INTERLEUKIN 1 RECEPTOR;
PLACEBO;
PROTEIN PRECURSOR;
TUMOR NECROSIS FACTOR RECEPTOR;
ADULT;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
DISEASE MARKER;
ENDOTOXEMIA;
FEMALE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IMMUNOMODULATION;
MAJOR CLINICAL STUDY;
MALE;
MEDIATOR RELEASE;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
RANDOMIZED CONTROLLED TRIAL;
STIMULUS RESPONSE;
ADOLESCENT;
ADULT;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
BIOLOGICAL MARKERS;
C-REACTIVE PROTEIN;
CALCITONIN;
ENDOTOXEMIA;
ENDOTOXINS;
ESCHERICHIA COLI;
FEMALE;
HALF-LIFE;
HUMANS;
IBUPROFEN;
IMMUNOGLOBULIN G;
INFLAMMATION;
INJECTIONS, INTRAVENOUS;
MALE;
MIDDLE AGED;
PLACEBOS;
PROTEIN PRECURSORS;
RADIOIMMUNOASSAY;
RECEPTORS, TUMOR NECROSIS FACTOR;
|
EID: 0035425571
PISSN: 00221899
EISSN: None
Source Type: Journal
DOI: 10.1086/322031 Document Type: Article |
Times cited : (64)
|
References (16)
|